1. Home
  2. HCI vs ANIP Comparison

HCI vs ANIP Comparison

Compare HCI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCI Group Inc.

HCI

HCI Group Inc.

HOLD

Current Price

$163.17

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.29

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCI
ANIP
Founded
2006
2001
Country
United States
United States
Employees
594
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
HCI
ANIP
Price
$163.17
$82.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$230.00
$110.00
AVG Volume (30 Days)
133.6K
274.3K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
$11.44
$21.01
Revenue Next Year
$7.67
$17.59
P/E Ratio
$9.97
$63.81
Revenue Growth
N/A
2.47
52 Week Low
$136.37
$62.61
52 Week High
$210.50
$99.50

Technical Indicators

Market Signals
Indicator
HCI
ANIP
Relative Strength Index (RSI) 61.24 58.41
Support Level $148.86 $76.73
Resistance Level $169.48 $83.61
Average True Range (ATR) 4.75 2.27
MACD 1.00 0.36
Stochastic Oscillator 87.46 89.81

Price Performance

Historical Comparison
HCI
ANIP

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: